Metrics as of 10/15/2026, 09:41 PM (Berlin time), refresh in progress.
CONMED Stock
CONMED Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Patrick J. Beyer
- Employees
- 3,900
- Market cap
- $1.4 B
- IPO
- 23/07/1987
CONMED Corporation functions as a medical technology enterprise specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Established in 1970, the company is headquartered in Largo, Florida. Its comprehensive product…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
CONMED stock: price history
1D
+5.3%
1W
+4.9%
1M
+0.8%
6M
+24.8%
YTD
+16.6%
1Y
+6.4%
2Y
-27.0%
5Y
-66.7%
10Y
+20.7%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~62% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about CONMED
Analyst assessment of CONMED
PRICE TARGET LOW
US$36.00
CONSENSUS
US$37.50
MEDIAN
US$37.50
PRICE TARGET HIGH
US$39.00
0
STRONG BUY
7
BUY
13
HOLD
1
SELL
0
STRONG SELL
21
TOTAL · Hold
As of: 30/07/2026
CONMED stock metrics
P/E
25.55
P/B
1.37
EV/EBITDA
11.94
RETURN ON EQUITY
2.2%
NET MARGIN
6.7%
DEBT/EQUITY
0.8
DIVIDEND YIELD
0.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
29,835,528
AVG. DAILY VOLUME (30D)
359,513
Insider transactions (SEC)
Kelderman Kim
Schwarzentraub Barbara J
Kaye Mark
Farkas Charles
Council LaVerne H
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about CONMED stock
What does CONMED do?
CONMED Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Patrick J. Beyer, the company employs around 3,900 people.
The IPO was on 23/07/1987; the stock trades on NYSE under the ticker CNMD.
What do analysts say about CONMED stock?
21 analysts rate the stock, the consensus is Hold (as of 30/07/2026).
The average price target is US$37.50, ranging from US$36.00 to US$39.00, with a median of US$37.50.
This is an external assessment, not a statement by Market Jury.
When does CONMED report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 62% stronger than usual.
Does CONMED pay a dividend?
Yes. The last dividend was US$0.20 per share, ex-date 15/09/2025, paid on 03/10/2025.
The dividend yield is 0.4% (as of 30/06/2026).
Which stocks are comparable to CONMED?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get CONMED stock analyzed?
Clicking "Analyze stock" lets five strategies assess CONMED against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.